학술논문
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
Document Type
Article
Author
Lanzetta, Paolo ; Korobelnik, Jean-François ; Heier, Jeffrey S ; Leal, Sergio; Holz, Frank G; Clark, W Lloyd; Eichenbaum, David; Iida, Tomohiro; Xiaodong, Sun; Berliner, Alyson J; Schulze, Andrea; Schmelter, Thomas; Schmidt-Ott, Ursula; Zhang, Xin; Vitti, Robert; Chu, Karen W; Reed, Kimberly; Rao, Rohini; Bhore, Rafia; Cheng, Yenchieh; Sun, Wei; Hirshberg, Boaz; Yancopoulos, George D; Wong, Tien Y
Source
In The Lancet 23-29 March 2024 403(10432):1141-1152
Subject
Language
ISSN
0140-6736